Search Results - "Chater, Peter"

Refine Results
  1. 1

    Efficacy and safety concerns over the use of mucus modulating agents for drug delivery using nanoscale systems by Chater, Peter I., Wilcox, Matthew D., Pearson, Jeffrey P.

    Published in Advanced drug delivery reviews (15-01-2018)
    “…Drug delivery to the mucus covered mucosae is fraught with difficulties and many different approaches have been developed to permeate the mucus barrier…”
    Get full text
    Journal Article
  2. 2

    Acceptability of alginate enriched bread and its effect on fat digestion in humans by Houghton, David, Wilcox, Matthew D., Brownlee, Iain A., Chater, Peter I., Seal, Chris J., Pearson, Jeffrey P.

    Published in Food hydrocolloids (01-08-2019)
    “…Lifestyle interventions and physical activity remain the cornerstone of obesity management, as pharmacological therapies (orlistat) are associated with…”
    Get full text
    Journal Article
  3. 3

    The effect of seaweed enriched bread on carbohydrate digestion and the release of glucose from food by Wilcox, Matthew D., Cherry, Paul, Chater, Peter I., Yang, Xing, Zulali, Moaz, Okello, Edward J., Seal, Chris J., Pearson, Jeffrey P.

    Published in Journal of functional foods (01-12-2021)
    “…•Seaweeds can reduce carbohydrate digestion in a physiologically relevant model.•Baking seaweed into bread can reduce its ability to inhibit carbohydrate…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Starch digestion in the upper gastrointestinal tract of humans by Brownlee, Iain A., Gill, Saloni, Wilcox, Matt D., Pearson, Jeff P., Chater, Peter I.

    Published in Starch - Stärke (01-09-2018)
    “…Starch provides a large proportion of the dietary energy consumed worldwide. The breakdown of dietary starch is driven by α‐amylase produced by the salivary…”
    Get full text
    Journal Article
  6. 6

    Biological activity of alginate and its effect on pancreatic lipase inhibition as a potential treatment for obesity by Houghton, David, Wilcox, Matthew D., Chater, Peter I., Brownlee, Iain A., Seal, Chris J., Pearson, Jeffrey P.

    Published in Food hydrocolloids (01-07-2015)
    “…Alginates are classed as a dietary fibre and have been shown to inhibit digestive enzymes in vitro, and therefore could be used as an obesity treatment. The…”
    Get full text
    Journal Article
  7. 7

    The MUC2 Gene Product: Polymerisation and Post-Secretory Organisation-Current Models by Stanforth, Kyle J, Zakhour, Maria I, Chater, Peter I, Wilcox, Matthew D, Adamson, Beth, Robson, Niamh A, Pearson, Jeffrey P

    Published in Polymers (12-06-2024)
    “…MUC2 mucin, the primary gel-forming component of intestinal mucus, is well researched and a model of polymerisation and post-secretory organisation has been…”
    Get full text
    Journal Article
  8. 8

    The properties of the mucus barrier, a unique gel--how can nanoparticles cross it? by Pearson, Jeffrey P, Chater, Peter I, Wilcox, Matthew D

    Published in Therapeutic delivery (01-04-2016)
    “…The key criterion for a nanoparticle drug-delivery system is the ability to produce substantial bioavailability without damaging the physiological protective…”
    Get full text
    Journal Article
  9. 9

    The role of seaweed bioactives in the control of digestion: implications for obesity treatments by Chater, Peter I, Wilcox, Matthew D, Houghton, David, Pearson, Jeffrey P

    Published in Food & function (01-11-2015)
    “…Seaweeds are an underutilised nutritional resource that could not only compliment the current western diet but potentially bring additional health benefits…”
    Get more information
    Journal Article
  10. 10

    ζ potential changing nanoparticles as cystic fibrosis transmembrane conductance regulator gene delivery system: an in vitro evaluation by Prüfert, Felix, Bonengel, Sonja, Köllner, Saskia, Griesser, Janine, Wilcox, Matthew D, Chater, Peter I, Pearson, Jeffrey P, Bernkop-Schnürch, Andreas

    Published in Nanomedicine (London, England) (01-11-2017)
    “…Aim of the study was the development of ζ potential changing nanoparticles as gene delivery system for the cystic fibrosis transmembrane conductance regulator…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Dietary fibre and weight loss: Where are we now? by Brownlee, Iain A., Chater, Peter I., Pearson, Jeff P., Wilcox, Matt D.

    Published in Food hydrocolloids (01-07-2017)
    “…“Dietary fibre” represents a wide spectrum of polysaccharides that escape digestion in the human gastrointestinal tract. The term has been widely associated…”
    Get full text
    Journal Article
  15. 15

    Letter: studies of salivary pepsin in patients with gastro‐oesophageal reflux disease by Dettmar, Peter William, Woodcock, Andrew David, Wilcox, Matthew David, Chater, Peter Ian, Pearson, Jeffrey Peter

    Published in Alimentary pharmacology & therapeutics (01-05-2019)
    “…Linked ContentThis article is linked to Race et al and Corfe et al papers. To view these articles, visit https://doi.org/10.1111/apt.15138 and…”
    Get full text
    Journal Article
  16. 16

    Inhibitory activity of extracts of Hebridean brown seaweeds on lipase activity by Chater, Peter Ian, Wilcox, Mathew, Cherry, Paul, Herford, Andrew, Mustar, Suraiami, Wheater, Hannah, Brownlee, Iain, Seal, Chris, Pearson, Jeffrey

    Published in Journal of applied phycology (01-04-2016)
    “…The effect of three Hebridean brown seaweeds on lipase activity was assessed using a turbidimetric lipase activity assay and an in vitro simulation of the…”
    Get full text
    Journal Article
  17. 17

    Alginate as a protease inhibitor in vitro and in a model gut system; selective inhibition of pepsin but not trypsin by Chater, Peter Ian, Wilcox, Mathew D., Brownlee, Iain A., Pearson, Jeffrey P.

    Published in Carbohydrate polymers (20-10-2015)
    “…•Alginate inhibits proteolytic activity of pepsin but not trypsin.•Level of pepsin inhibition correlates with alginate F[M].•An in vitro model gut system was…”
    Get full text
    Journal Article
  18. 18

    Inhibitory activities of three Malaysian edible seaweeds on lipase and α-amylase by Balasubramaniam, Vimala, Mustar, Suraiami, Mustafa Khalid, Norhayati, Abd Rashed, Aswir, Mohd Noh, Mohd Fairulnizal, Wilcox, Matthew D., Chater, Peter I., Brownlee, Iain A., Pearson, Jeffrey P.

    Published in Journal of applied phycology (01-10-2013)
    “…Ethanol extracts, dried powders and fibres (total and soluble fibre) of the tropical red algae Kappaphycus alvarezii , Kappaphycus striatus and Eucheuma…”
    Get full text
    Journal Article
  19. 19

    Bile acids in laryngopharyngeal refluxate: Will they enhance or attenuate the action of pepsin? by Ali, Mahmoud S., Parikh, Shruti, Chater, Peter, Pearson, Jeffrey P.

    Published in The Laryngoscope (01-02-2013)
    “…Objectives/Hypothesis: To assess if, as previously reported in the literature, bile acids inhibit pepsin activity, resulting in pepsin having a less important…”
    Get full text
    Journal Article
  20. 20

    ζ potential changing nanoparticles as cystic fibrosis transmembrane conductance regulator gene delivery system: an by Prüfert, Felix, Bonengel, Sonja, Köllner, Saskia, Griesser, Janine, Wilcox, Matthew D, Chater, Peter I, Pearson, Jeffrey P, Bernkop-Schnürch, Andreas

    Published in Nanomedicine (London, England) (01-11-2017)
    “…Aim of the study was the development of ζ potential changing nanoparticles as gene delivery system for the cystic fibrosis transmembrane conductance regulator…”
    Get full text
    Journal Article